The impact of methicillin resistance on morbidity and mortality among patients with severe Staphylococcus aureus infection remains highly controversial. We retrospectively analyzed patients with mediastinitis due to methicillin-susceptible S. aureus (MSSA; 145 patients) or methicillin-resistant S. aureus (MRSA; 73 patients) who were treated with closed drainage using Redon catheters. Initial empirical antibiotic therapy was appropriate for every patient. Patients with MRSA mediastinitis were older, had higher disease severity scores at admission to the intensive care unit (ICU), and had longer periods of MRSA incubation. Multivariate analysis revealed that ICU mortality was associated with age of у65 years, incubation time of р15 days, bacteremia, higher Acute Physiology and Chronic Health Evaluation II score, and receipt of mechanical ventilation у2 days after surgical debridement, but not with methicillin resistance. After adjustment, durations of mechanical ventilation and Redon catheter drainage were similar for both groups (for patients infected with MRSA, only the time to mediastinal effluent sterilization remained longer). Methicillin resistance did not significantly affect ICU mortality among patients with poststernotomy mediastinitis who benefited from optimal treatments.
Predisposing factors for methicillin-resistant Staphylococcus aureus (MRSA) infection include severe underlying conditions, prolonged hospital stay, previous antibiotic treatment, and nasal MRSA carriage [1] [2] [3] [4] . Despite continuous efforts to control MRSA transmission in the hospital, especially in intensive care units (ICUs), MRSA infection remains a major worldwide concern, and the true impact of MRSA infection on morbidity and mortality remains highly controversial. Although some studies [1, [5] [6] [7] [8] [9] [10] [11] , including a recent meta-analysis of S. aureus bacteremia [12] , found higher mortality rates among patients with MRSA in-fection than among those infected with methicillin-susceptible S. aureus (MSSA), many studies failed to identify a relationship between MRSA and mortality [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] . These results may reflect the end points chosen (crude vs. infection-related mortality), major differences in patient populations, preexisting comorbidities, severity of S. aureus infection at the time of diagnosis, sites of infection, and, above all, high rates of inappropriate empirical antibiotic regimens prescribed for treatment of MRSA infections.
S. aureus is also the most common bacterial pathogen cultured from mediastinal samples obtained from patients with poststernotomy mediastinitis, a dreadful complication of cardiac surgery, and a significant percentage of these nosocomial infections are caused by MRSA [25] [26] [27] [28] . We and others have shown that closed drainage with Redon catheters for mediastinitis is a simple technique that reduces primary treatment failure, superinfections, and mortality rates, compared with continuous mediastinal irrigation [28] [29] [30] [31] [32] . Now, we use only this mediastinal drainage technique, except for massive sternum and/or skin necrosis, which requires initial open-wound treatment. Moreover, as soon as bacterial samples have been collected, we prescribe empirical antibiotic therapy combining cefamandole, vancomycin, and gentamicin to every patient suspected of having deep sternal wound infection with gram-positive cocci.
The objective of this study was to analyze the impact of methicillin resistance on a large and homogeneous group of patients with S. aureus poststernotomy mediastinitis who had benefited from highly standardized medical and surgical treatments.
PATIENTS AND METHODS
Setting. This study was conducted in a 17-bed ICU in a teaching hospital. The protocol accorded with the ethical standards of the Committee for the Protection of Human Research Subjects at Groupe Hospitalier Pitié-Salpêtrière (Paris, France). No informed consent was obtained, because this epidemiologic study did not modify existing diagnostic or therapeutic strategies.
Study objective and design. The aim of the study was to evaluate the effects of methicillin resistance on the morbidity and mortality associated with S. aureus mediastinitis. Although all data had been collected prospectively throughout the study period, the analyses were retrospective.
Patients and mediastinitis management. All patients who were consecutively treated from January 1989 through December 2001 for S. aureus mediastinitis in our ICU were included (patients with polymicrobial infection or mediastinitis caused by other bacteria were excluded). These patients were referred from different local, secondary, or tertiary surgical centers. Acute poststernotomy mediastinitis was defined as a deep wound infection associated with sternal osteomyelitis-with or without infected retrosternal space-that needed surgical debridement. The infection was suspected in the presence of local signs (sternal instability, pain, tenderness, or wound discharge), general clinical features (fever or unexplained poor postoperative condition), and laboratory findings (leukocytosis and blood culture positive for S. aureus). Confirmation of mediastinal infection was obtained by positive findings of direct examination and results of culture of either transcutaneous needle aspirates of the deep mediastinum after careful skin disinfection or surgical material. Surgical debridement was performed as soon as clinical and/or bacterial evidence of infection was obtained, and the closed-drainage technique with Redon catheters was used for every patient included in the study. Every 3 days, samples of drainage fluid were cultured. After at least 10 days of closed drainage and if the drainage fluid was sterile, Redon catheters were progressively removed (2-3 cm/day).
Microbiological methods and antibiotic therapy. Direct examination (with Gram staining) and cultures of mediastinal needle aspirates and/or surgical material were performed for every patient included in the study. As soon as Staphylococcus mediastinitis was suspected, and before surgical debridement, empirical intravenous antibiotic therapy combining cefamandole, vancomycin, and gentamicin was instituted for every patient (except for 1 patient in the MRSA group, who was allergic to b-lactams and received only vancomycin and gentamicin). S. aureus was identified using standard laboratory procedures, and tests for methicillin resistance were performed in accordance with the recommendations of the Antibiogram Committee of the French Microbiological Society [33] . A double test was realized: incubation for b-lactam (oxacillin) resistance at 30ЊC for 24 and 48 h and detection of methicillin resistance on saline Mueller-Hinton agar at 37ЊC. All but b-lactam antibiotics were incubated at 37ЊC for 24 h. Thereafter, patients with MSSA mediastinitis were treated sequentially with cefamandole and gentamicin for 3-5 days, cefamandole plus rifampin and ofloxacin for 15-18 days, and rifampin and ofloxacin for 3 weeks. Patients with MRSA infection were treated with vancomycin and 1-2 other antibiotics, on the basis of bacterial susceptibility data (antibiotic treatment duration was also 6 weeks for this group). Maintenance doses of vancomycin were adjusted to obtain trough levels у20 mg/mL (measurement of serum vancomycin concentrations was kindly performed by R. Farinotti at the Laboratoire de Toxicologie, Hôpital Bichat; Paris, France). Data collection. Each patient's hospital chart was constituted prospectively, and the following data were recorded: age; sex; type of initial cardiac operation; severity of underlying medical condition, stratified according to the criteria of McCabe and Jackson [34] ; APACHE II score [35] ; presence or absence of shock, defined as systolic pressure !90 mm Hg that was unresponsive to fluid treatment or required vasoactive drugs; and organ dysfunction(s) and/or organ dysfunction infection (ODIN) score [36] . All these parameters were recorded within 24 h of surgical debridement, with the worst value for each variable being retained for disease-severity score calculation. In addition, the following parameters were recorded: mediastinitis incubation time, defined as the interval between the initial cardiac operation and surgical debridement; and concomitant bacteremia and endocarditis. We also determined the percentages of patients with primary mediastinitis (patients referred to our ICU with the primary diagnosis of mediastinitis) and patients with secondary mediastinitis (patients referred to our unit for treatment of another major cardiac surgery complication who developed their first signs of mediastinitis 148 h after admission to our ICU) [28] .
Outcome measures.
Outcome measures included ICU mortality; duration of mechanical ventilation (MV); duration of ICU stay; time to mediastinal effluent sterilization, calculated P р .10 were entered into the model, and data on methicillin resistance were forced into the final model as a covariate. Age, incubation time, and duration of MV after surgical debridement were categorized using the median values as the thresholds before being entered into the multivariate model. Kaplan-Meier survival analysis was used to estimate ICU survival, duration of MV, duration of Redon catheter drainage, and time to mediastinal effluent sterilization for patients with mediastinitis due to MRSA or MSSA infection, and the 2 groups were compared using the log-rank test. Then, the analysis was repeated-adjusting for age, incubation time, type of mediastinal infection (primary vs. secondary mediastinitis), and APACHE II scoreusing a Cox proportional hazards model. Statistical significance was defined as . Analyses were performed using StatView, P ! .05 version 5.0 (SAS Institute), and SPSS, version 11.0 (SPSS), software.
RESULTS

Study population.
Of the 515 patients treated in our ICU for poststernotomy mediastinitis from January 1989 through December 2001, 218 developed monomicrobial S. aureus infections, which were treated with surgical debridement and Redon catheter drainage. MRSA was recovered from 73 patients (33%). Demographic and clinical characteristics of MRSA-and MSSA-infected patients are shown in table 1. Compared with MSSA-infected patients, those with MRSA mediastinitis were older, had a longer mediastinitis incubation time, and had signs of more severe disease (the difference in APACHE II scores between the 2 groups tended toward statistical significance). The percentage of patients who developed mediastinitis у48 h after ICU admission for severe postoperative organ failure was higher in the MRSA group. No statistically significant differences were noted for male sex, severity of underlying medical condition, type of initial cardiac surgery, and percentages of patients with associated bacteremia and endocarditis. (  ; table 3 ). Kaplan-Meier estimates of the P p .41 cumulative probability of ICU survival as a function of the number of days after mediastinal debridement did not differ significantly for the 2 groups ( figure 1A) . Results of univariate and multivariate analyses of factors potentially associated with ICU mortality are reported in table 4. As indicated, significant predictors of ICU mortality according to the multivariate analysis were age у65 years, incubation time р15 days, higher APACHE II score at ICU admission, bacteremia, and MV у2 days after surgical debridement, but not methicillin resistance, as determined by univariate analysis or when it was forced into the final multivariate model. Furthermore, the same predictors of ICU mortality were identified and retained when the analyses were restricted to patients admitted to our ICU for primary mediastinitis.
Mediastinitis-associated morbidity. Length of ICU stay, duration of MV, and time to mediastinal effluent sterilization were significantly longer for the MRSA group (table 3) . KaplanMeier estimates of the cumulative probabilities of time to mediastinal fluid sterilization, duration of continuous Redon catheter drainage, and duration of MV are shown in figure 1B-1D 
DISCUSSION
The aim of this study was to evaluate the impact of methicillin resistance on the outcome of S. aureus poststernotomy mediastinitis. Of the 515 patients with postoperative deep sternal wound infections hospitalized in our ICU from January 1989 through December 2001, 218 developed a monomicrobial S. aureus infection, which was treated with surgical debridement and Redon catheter drainage. Univariate and multivariate analyses did not associate MRSA with ICU mortality and, after adjustment, durations of MV and Redon catheter drainage were similar for both groups (for patients in the MRSA group, only the time to mediastinal effluent sterilization remained longer).
Our results confirm and extend those of recent large-cohort studies on bacteremic S. aureus infections. The multivariate analyses of data from the 2 largest studies published to date (908 [15] and 504 [24] patients) did not recognize MRSA bacteremia as a factor predictive of mortality, even though crude hospital mortality rates were significantly higher for the MRSA groups.
One of the major confounders in studying MRSA and MSSA pathogenicity might be the higher rates of inappropriate empirical antimicrobial treatments that have been prescribed to MRSA-infected patients, which ranged from 8% to 55% in previous studies [8, 13, 15, 16, 37] . Pertinently, this factor was independently associated with hospital mortality in the largest investigation of S. aureus bacteremia [15] . Inappropriate empirical antimicrobial treatment was also found to be the most important independent determinant of hospital mortality among critically ill patients in a study of various infections; inappropriate antibiotics had been initially administered to 60% of the patients in the MRSA group, compared with 9% of those in the MSSA group [38] . Using a combination of vancomycin, cefamandole, and gentamicin as empirical therapy for every patient suspected of having S. aureus poststernotomy mediastinitis, we achieved 100% coverage with the first-line antibiotic treatment for both groups of patients, which may have accounted for the absence of a significant difference between their mortality rates in this study.
Combining vancomycin and cefamandole as empirical antibiotic therapy for suspected nosocomial S. aureus infections may indeed be beneficial for patients infected with MRSA or MSSA. The results of in vitro studies suggested b-lactam and glycopeptide synergy against MRSA. For instance, using killingcurve assays, Rochon-Edouard et al. [39] showed that combining cefazolin or imipenem with vancomycin resulted in higher bactericidal rates than did vancomycin alone against some MRSA isolates. Conversely, treating MSSA-infected patients with vancomycin alone might be deleterious. Indeed, it was shown that injection drug users treated for MSSA endocarditis with empirical vancomycin therapy alone had higher infection-related mortality, slower clinical response, and longer duration of bacteremia than did those who received a b-lactamcontaining empirical antibiotic regimen [40] . Also, MSSA bacteremic pneumonia-associated mortality was significantly higher among patients who received vancomycin than among those treated with cloxacillin [37] . Finally, in a study comparing perioperatively administered vancomycin or cefazolin prophylaxis for heart surgery-associated infection, MSSA wound-site infections were significantly more frequent in the vancomycin group [41] .
Although, in the present work, mortality and morbidity (with the exception of an increased time to sterilization of mediastinal fluid drainage for MRSA-infected patients) were similar, after adjustment, for both groups of patients, other studies have reported higher morbidity rates among MRSA-infected pa- tients. In a study of S. aureus bacteremia in neutropenic patients, Marty et al. [22] found that results of cultures of blood samples obtained from MRSA-infected patients remained positive significantly longer, although mortality did not differ between MRSA-and MSSA-infected patients. Time to mediastinal effluent sterilization also tended to be longer in a group of 15 patients with MRSA mediastinitis [6] . Several factors may explain these differences. First, MRSA-infected patients were older, had signs of more severe disease at ICU admission, and developed mediastinitis more frequently after ICU admission for major postoperative complication(s) than did MSSAinfected patients. This debilitated condition may alter the natural immune response to S. aureus infection and may delay wound healing. Second, it has been suggested that vancomycin may have a less rapid bactericidal effect than do semisynthetic penicillins, especially for the treatment of deep-seated S. aureus infections, such as endocarditis [42, 43] , which, therefore, may explain the delay observed in the time to mediastinal effluent sterilization. Third, although it has been advanced that MRSA strains might be more virulent, in vitro and in vivo experimental results do not support this hypothesis [23, [44] [45] [46] [47] [48] . However, this higher MRSA-associated morbidity did not seem to affect mortality in the present study, because time to mediastinal effluent sterilization, duration of Redon catheter drainage, and failure of empirical treatment to resolve local infection were not associated with ICU death. We are aware of several limitations to the present study. First, it can be argued that our population and/or the types of patient care may have changed over the 13 years of the study. However, we do not think that this is the case: our mediastinal and antibiotic treatment policies [28, 30] have remained constant over time, as have the annual mortality rates (data not shown). Second, we did not classify mediastinal infections according to the system proposed by El Oakley and Wright [49] , because many of our patients were being treated in our department before its publication. Third, we cannot exclude the possibility that this study might have yielded different results if our database had included information such as the interval between first clinical manifestations of infection and the initiation of antimicrobial therapy, the severity of illness just before the onset of mediastinitis, or the events occurring late after ICU discharge (e.g., delayed relapse of the mediastinal infection). Finally, the conclusions of this study may not be applicable to other types of severe S. aureus infections, such as nosocomial pneumonia or endocarditis.
In summary, we conclude that, despite a significantly longer time to surgical wound sterilization, methicillin resistance does not significantly affect ICU mortality of patients with S. aureus poststernotomy mediastinitis who have benefited from optimal medical and surgical treatments. sor R. Farinotti (Phamacie-Toxicologie, Hô pital Bichat; Paris), for measurement of serum vancomycin concentrations.
